Dual antiplatelet therapy and operative medicine : Open questions despite guidelines?
Summary of "Dual antiplatelet therapy and operative medicine : Open questions despite guidelines?"
No Summary Available
Affiliation
Univ.-Klinik für Anästhesiologie und Intensivmedizin, Medizinische Universität Graz, Auenbruggerplatz 29, 8036, Graz, Österreich, anaesthesie@meduni-graz.at.
Journal Details
This article was published in the following journal.
Name: Der Anaesthesist
ISSN: 1432-055X
Pages:
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/22875061
- DOI: http://dx.doi.org/10.1007/s00101-012-2069-2
Medical and Biotech [MESH] Definitions
Forensic Medicine
The application of medical knowledge to questions of law.
Examination Questions
Works consisting of compilations of questions and answers pertaining to a particular subject, used for study and review.
Fetal Therapies
Prenatal interventions to correct fetal anomalies or treat FETAL DISEASES in utero. Fetal therapies include several major areas, such as open surgery; FETOSCOPY; pharmacological therapy; INTRAUTERINE TRANSFUSION; STEM CELL TRANSPLANTATION; and GENE THERAPY.
Neuronavigation
Intraoperative computer-assisted 3D navigation and guidance system generally used in neurosurgery for tracking surgical tools and localize them with respect to the patient's 3D anatomy. The pre-operative diagnostic scan is used as a reference and is transferred onto the operative field during surgery.
Dual Specificity Phosphatase 3
A dual specificity phosphatase subtype that plays a role in intracellular signal transduction by inactivating MITOGEN-ACTIVATED PROTEIN KINASES. It has specificity for EXTRACELLULAR SIGNAL-REGULATED MAP KINASES.
PubMed Articles
The goal of this study was to evaluate shorter duration (3 months) dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation.
Safety of Endoscopic Sphincterotomy in Patients under Dual Antiplatelet Therapy.
Background/Aims: Dual antiplatelet therapy has to be used for at least one month after placement of bare metal coronary stents and for a minimum of one year after placement of drug eluting stents. Bec...
Platelet function: new drugs, new assays : Possible impacts on operative medicine?
Dual antiplatelet therapy with aspirin and a P2Y12 receptor blocker is a well-established strategy to prevent thrombotic complications in patients with acute coronary syndromes (ACS) and after percuta...
Dual antiplatelet treatment in patients candidates for abdominal surgery.
Dual antiplatelet treatment in patients candidates for abdominal surgery With the increasing diffusion of percutaneous interventions (PCI), surgeons are often faced with the problem of operating on pa...
Risk of wound hematoma at carotid endarterectomy under dual antiplatelet therapy.
BACKGROUND AND PURPOSE: This study aims to assess perioperative incidence of wound hematoma and bleeding in patients who underwent carotid endarterectomy (CEA) under dual antiplatelet therapy. METHODS...
Clinical Trials
The Dual Antiplatelet Therapy Study (DAPT Study)
The DAPT Study is a double blind randomized controlled trial intended to determine the appropriate duration for dual antiplatelet therapy (the combination of aspirin and a second anti-clot...
Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent
To evaluate whether the cilostazol reduce neointimal hyperplasia after ZES (Zotarolimus-eluting stents) implantation, the investigators performed double-blind,randomized, multicenter, pros...
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V USA is a prospective, multi-center, multi-cohort postapproval study. The objectives of this study are - To evaluate XIENCE V EECSS continued safety and effectiveness during co...
To determine the rate of symptomatic and asymptomatic gastrointestinal erosions and ulcerations in patients on dual antiplatelet (aspirin and clopidogrel) therapy after percutaneous corona...
The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent
The purpose of this study to determine whether the dual antiplatelet therapy (aspirin and clopidogrel) for 3 months after coronary implantation of zotarolimus-eluting stent is safe in term...
